BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
3.915
-0.055 (-1.39%)
Jul 6, 2026, 3:58 PM CET
Market Cap340.88M -3.2%
Revenue (ttm)266.02M +12.8%
Net Income4.05M
EPS0.05
Shares Out 85.86M
PE Ratio84.29
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,365
Open3.950
Previous Close3.970
Day's Range3.915 - 3.950
52-Week Range3.650 - 4.700
Beta0.17
Analystsn/a
Price Targetn/a
Earnings DateSep 15, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements